Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks with high potential. H.C. Wainwright analyst Joseph Pantginis reiterated a bullish stance on Viking Therapeutics, Inc. (NASDAQ ...

“We were more than happy to donate our products to the department,” notes Jeremy Morton, CEO of Viking. “As soon as we found out that the building was undergoing the installation of fire protection, ...

The Oseberg longship – considered one of the most important historical discoveries of the Viking age — voyaged to its final destination last month. But the journey it took to get there was complicated ...

Viking Therapeutics, Inc. (VKTX) closed at $27.88 in the latest trading session, marking a +1.86% move from the prior day. This move outpaced the S&P 500's daily gain of 0.06%. Meanwhile, the Dow ...

Installing Fortune Auto coilovers on my Subaru WRX for sharper handling and a lower stance. Mike Johnson Shifts Tone On Health Care As Shutdown Drags On Bill Belichick's latest Patriots ban has Drake ...

Samuel Goldwyn Films has acquired the U.S. distribution rights for Anders Thomas Jensen’s The Last Viking, starring Mads Mikkelsen. The Last Viking marks Anders Thomas Jensen’s sixth feature as a ...

Oslo — Three 1,200-year-old Viking ships that have stood the test of time are embarking on their final and possibly riskiest journey to their new forever home in Norway. The first to make the move is ...

Dr. Joel S. Levine is a consultant and subject matter expert for the NASA Engineering and Safety Center in the areas of space and planetary environments. Dr. Levine worked for NASA from 1970 to 2011 ...

EXCLUSIVE: Oscar-winning Danish director Anders Thomas Jensen lands in Venice this weekend with dark comedy The Last Viking, reuniting him with actors Mads Mikkelsen and Nikolaj Lie Kaas who have ...

Denmark's National Museum has unveiled what it described as the first "portrait" of a Viking: a miniature 10th-century figurine depicting a man with an imperial moustache, braided beard and ...

A Viking Therapeutics drug that hits two targets to spark weight loss achieved the goals of a closely watched mid-stage clinical trial, but with results that also show many patients stopped the ...

Viking Therapeutics' new GLP-1 weight loss pill, VK2735, helped patients shed 12.2% of their body weight in 13 weeks. The pill is proving "safe and well-tolerated." However, one-fifth of participants ...